Cook Medical Incorporated designs, manufactures, and distributes minimally invasive medical devices for diagnostic and therapeutic procedures in the United States and internationally. Its products include catheters, wire guides, introducer sheaths, stents, embolization coils, vena cava filters, aortic endovascular grafts, airway management devices, central venous catheter devices, and drainage products. The company also provides FluoroSet, a radiographic tubal assessment set to deliver fluoroscopic evaluation results; and histology needles for endoscopic ultrasound. In addition, it develops Hercules 3 Stage Esophageal Balloon to treat gastrointestinal structures; NavAlign delivery system, a deployment system designed to minimize the risk of vessel trauma and streamline filter placement; Cantata superselective microcatheters; deflecting endoscopic system that enables physicians to manage a stone case with only Cook products, and for use in other kidney and bladder procedures; and enteral feeding products that are used for gastrostomy feeding. The companys products are used for endovascular therapy, critical care medicine, general surgery, diagnostic and interventional procedures, bioengineered tissue replacement and regeneration, gastroenterology and endoscopy procedures, urology, and obstetrics and gynecology. It integrates medical devices, drugs, and biologics to enhance patient safety and improve clinical outcomes. Cook Medical Incorporated was founded in 2003 and is based in Bloomington, Indiana. The company has distribution centers in Baesweiler, Germany; Bloomington, Indiana; and Shanghai, China, as well as a R&D centre in Limerick, Ireland. Cook Medical Incorporated operates as a subsidiary of Cook Group Incorporated.
